Christine A. Carberry
No más puestos en curso
Perfil
Christine A.
Carberry worked as Vice President-Program & Alliance Management at Biogen, Inc. She then worked as Chief Operating Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she was VP-Technical Operations & Alliance Management at FORUM Pharmaceuticals, Inc. from 2014 to 2016.
Carberry holds a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.
Antiguos cargos conocidos de Christine A. Carberry.
| Empresas | Cargo | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Director de Operaciones | 12/12/2018 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | 01/05/2016 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Formación de Christine A. Carberry.
| Boston University | Graduate Degree |
| University of New Hampshire | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christine A. Carberry
